GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Purchased by Nomura Asset Management Co. Ltd.

Nomura Asset Management Co. Ltd. boosted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 9.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 145,996 shares of the company's stock after buying an additional 12,908 shares during the period. Nomura Asset Management Co. Ltd.'s holdings in GE HealthCare Technologies were worth $13,702,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. LGT Financial Advisors LLC boosted its stake in GE HealthCare Technologies by 1,673.3% in the third quarter. LGT Financial Advisors LLC now owns 266 shares of the company's stock valued at $25,000 after acquiring an additional 251 shares in the last quarter. Fred Alger Management LLC acquired a new stake in shares of GE HealthCare Technologies in the 2nd quarter worth $26,000. Capital Performance Advisors LLP purchased a new position in GE HealthCare Technologies during the 3rd quarter worth $26,000. Ashton Thomas Securities LLC acquired a new position in GE HealthCare Technologies during the 3rd quarter valued at about $26,000. Finally, Elkhorn Partners Limited Partnership purchased a new stake in GE HealthCare Technologies in the second quarter valued at about $31,000. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, CEO Roland Rott sold 3,577 shares of the business's stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total value of $309,338.96. Following the completion of the sale, the chief executive officer now directly owns 24,298 shares in the company, valued at $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.27% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on GEHC shares. Stifel Nicolaus boosted their price target on GE HealthCare Technologies from $100.00 to $102.00 and gave the stock a "buy" rating in a research note on Monday, September 30th. Wells Fargo & Company boosted their target price on shares of GE HealthCare Technologies from $95.00 to $96.00 and gave the stock an "overweight" rating in a research report on Thursday, October 31st. BTIG Research raised shares of GE HealthCare Technologies from a "neutral" rating to a "buy" rating and set a $100.00 price target for the company in a report on Wednesday, September 18th. JPMorgan Chase & Co. started coverage on shares of GE HealthCare Technologies in a report on Monday, September 9th. They set a "neutral" rating and a $90.00 price objective on the stock. Finally, UBS Group lowered GE HealthCare Technologies from a "neutral" rating to a "sell" rating and reduced their target price for the stock from $84.00 to $74.00 in a research note on Thursday, September 26th. One research analyst has rated the stock with a sell rating, four have issued a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, GE HealthCare Technologies has an average rating of "Moderate Buy" and a consensus target price of $95.46.

GE HealthCare Technologies Stock Performance

Shares of GEHC stock traded down $1.12 on Thursday, hitting $81.63. The company had a trading volume of 2,364,256 shares, compared to its average volume of 3,053,688. GE HealthCare Technologies Inc. has a twelve month low of $71.31 and a twelve month high of $94.55. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The firm has a market cap of $37.29 billion, a P/E ratio of 22.73, a price-to-earnings-growth ratio of 2.91 and a beta of 1.08. The company has a 50-day moving average price of $86.21 and a 200-day moving average price of $83.71.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, topping the consensus estimate of $1.06 by $0.08. The business had revenue of $4.86 billion for the quarter, compared to analyst estimates of $4.87 billion. GE HealthCare Technologies had a return on equity of 25.19% and a net margin of 8.56%. The business's quarterly revenue was up .9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.99 EPS. As a group, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current fiscal year.

GE HealthCare Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Tuesday, January 14th will be issued a $0.035 dividend. This is a boost from GE HealthCare Technologies's previous quarterly dividend of $0.03. The ex-dividend date is Tuesday, January 14th. This represents a $0.14 dividend on an annualized basis and a yield of 0.17%. GE HealthCare Technologies's payout ratio is presently 3.85%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.